Form 4: VNRX CEO Reynolds Awarded 486K Restricted Stock Units

VOLITIONRX LTD's President and CEO, Cameron John Reynolds, was awarded 486,000 restricted stock units in lieu of cash compensation, vesting through February 2027.

Summary

• Cameron John Reynolds, President and CEO, and a Director of VOLITIONRX LTD (VNRX), was awarded 486,000 restricted stock units (RSUs).
• The RSUs were granted on February 26, 2026, under the Issuer's 2024 Stock Incentive Plan.
• This award was made in lieu of cash compensation that would otherwise have been owed to Mr. Reynolds.
• The RSUs will be earned in twelve approximately equal monthly installments, commencing on March 1, 2026.
• Once earned, the RSUs are subject to additional time-based vesting in a single installment on February 26, 2027.
• Vesting is generally contingent upon Mr. Reynolds' continued service throughout each applicable earning and vesting date.
• Upon vesting and settlement, Mr. Reynolds will receive common stock shares equal to the number of earned and vested RSUs.
• Following this transaction, Mr. Reynolds directly beneficially owns 3,115,547 shares of common stock.
• Indirect beneficial ownership includes 1,007,718 shares held by Concord International, Inc. (where Mr. Reynolds is the majority shareholder) and 34,076 shares held by his spouse.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it represents a standard compensation practice, it reinforces management's alignment with shareholder interests and commitment to the company's future performance.

Positives

• The award of restricted stock units aligns the CEO's long-term interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
• Granting RSUs in lieu of cash compensation helps conserve the company's cash resources.
• The multi-year vesting schedule acts as a retention mechanism for key management.

Negatives

• The issuance of new shares upon RSU vesting could lead to a slight dilution for existing shareholders, although this is a common practice for executive compensation.

Risks

• The RSUs are subject to continued service by the reporting person throughout each applicable earning and vesting date, meaning the award could be forfeited if employment ceases prematurely.

Future Outlook

The vesting schedule for the restricted stock units, extending through February 2027, indicates a continued commitment from the CEO to the company's long-term performance and growth, as his compensation is directly tied to the stock's future value.

Industry Context

StockSavvy.ai notes that the award of restricted stock units (RSUs) is a common and widely accepted form of executive compensation across various industries. This practice is favored for its ability to align the interests of executives with those of shareholders by tying a significant portion of their compensation to the company's stock performance and long-term value creation. It also serves as a strong retention tool, as vesting schedules typically span several years.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for executive compensation is a standard practice across publicly traded companies, comparable to compensation structures seen in biotech and diagnostic firms of similar market capitalization.
• The multi-year vesting schedule (12 monthly installments followed by a single additional installment) is typical for long-term incentive plans designed to retain key executives and align their performance with shareholder value over an extended period.

Corporate Governance

Related Party Transactions

• Cameron John Reynolds holds indirect beneficial ownership of 1,007,718 shares through Concord International, Inc., where he is the majority shareholder and shares voting and dispositive control.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon RSU vesting, but also benefit from increased alignment of CEO's interests with long-term stock performance.
• Employees (CEO): Receives significant equity compensation, incentivizing continued service and performance.

Next Steps

• The restricted stock units will begin earning in twelve approximately equal monthly installments commencing on March 1, 2026.
• Additional time-based vesting for the RSUs will occur in a single installment on February 26, 2027.
• Upon vesting and settlement, Cameron John Reynolds will receive shares of common stock.

Key Dates

Recommendation

This Form 4 reports a routine executive compensation award, which is a neutral event for the stock's immediate valuation. It signifies management's continued commitment but does not introduce new fundamental information to warrant a change in investment stance. Investors should maintain their current position while monitoring broader company performance and market conditions.

Keywords

VNRX, VolitionRx, Cameron Reynolds, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Stock Incentive Plan